(Bloomberg) -- A new DNA-editing technique called CRISPR is captivating scientists- and investors- with the possibility we can fix malfunctioning genes in parts of the body, and thereby remove certain diseases. \u0010\u0010This radio hour explains the science and investment behind CRISPR, its heated patent dispute and the companies using it. And we dive into the ethical implications of editing genes in humans and animals.